QRVO vs SPRO · P/E 27, rev $3.68B vs P/E 9.6, rev $258.0K
Qorvo Inc (QRVO) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
QRVO currently screens at market cap $8.54B and trailing P/E 26.8. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the QRVO and SPRO stock pages for the full models.
Not investment advice.